A former CEO is pleading guilty to participating in an opioid kickback scheme.
The former head of Insys Therapeutics said the company bribed doctors to boost prescriptions of a highly addictive fentanyl spray. The powerful medication was meant for cancer patients with severe pain.
Michael Babich's guilty plea agreement was revealed by prosecutors in court documents filed this week.
Babich was among several executives of the Arizona-based company charged in the closely-watched case scheduled to go to trial next month.
Insys founder John Kapoor and several others have pleaded not guilty.
